Safety and Efficacy of the VASCADE MVP® XL Venous Vascular Closure System for Management of Femoral Venotomy Following Catheter‐Based Interventions Utilizing 16‐17F OD Sheaths: The AMBULATE EXPAND Trial
The study results demonstrate that the VASCADE MVP XL device provides safe and effective percutaneous closure of femoral venous access sites after catheter-based procedures using 16-17F OD sheaths. Compared to standard performance goals from manual compression, the VASCADE MVP XL significantly reduced time to ambulation, hemostasis, discharge eligibility, and overall post-procedure time.
Authors
- S. Mittal
- Maheer Gandhavadi
- Joseph Banno
- Bruce G. Hook (ORCID: https://orcid.org/0000-0001-7536-4587)
- Zayd Eldadah (ORCID: https://orcid.org/0000-0003-1872-662X)
- David B. De Lurgio
- H. Thomas McElderry
- Amin Al‐Ahmad
- T. Jared Bunch
Institutions
- Emory Healthcare (US)
- Overlake Hospital Medical Center (US)
- University of Utah Hospital (US)
- University of Alabama at Birmingham (US)
- Valley Health System (US)
- Lahey Medical Center (US)
- St David's Medical Center (US)
- Texas Cardiac Arrhythmia (US)
- MedStar Heart & Vascular Institute (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1111/jce.70324
- Primary Topic
- Vascular Procedures and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00